An oncogenic form of the Flt-1 kinase has a tubulogenic potential in a sinusoidal endothelial cell line

European Journal of Cell Biology

Volumn 79, Issue 2, 2000, Pages 130-143

  Maru, Yoshiro ^a   Hirosawa, Hiroshige ^a   Shibuya, Masabumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

BCR ABL; Endothelial cells; Flt 1; Kinase; Tubulogenesis

Indexed keywords

BCR ABL PROTEIN; GELATINASE A; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHOTRANSFERASE; PROTEIN SUBUNIT; SERINE PROTEINASE INHIBITOR; UROKINASE;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; CARCINOGENESIS; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CONTROLLED STUDY; ENDOTHELIUM CELL; GROWTH STIMULATION; LIVER; LIVER SINUSOID; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALIA;

EID: 0034005856     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1078/S0171-9335(04)70015-1     Document Type: Article

References (51)

1. Brooks, P. C., Silltetti, S., von Schalscha, T. L., Friedlander, M., Cheresh, D. A. (1998): Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92, 391-400.
2. Clark, E. A., Hynes, R. O. (1996): Ras activation is necessary for integrin-mediated activation of extracellular signal-regulated kinase 2 and cytosolic phospholipase A2 but not for cytoskeletal organization. J. Biol. Chem. 271, 14814-14818.
3. Esser, S., Wolburg, K., Wolburg, H., Breier, G., Kurzchalia, T., Risau, W. (1998): Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell. Biol. 140, 947-959.
4. Ferrara, N., Davis-Smith, T. (1997): The biology of vascular endothelial growth factor. Endocrine Rev. 18, 4-25.
5. Fibbi, G., Caldini, R., Chevanne, M., Pucci, M., Schiavone, N., Morbidelli, L., Parenti, A., Granger, H. J., Del Rosso, M., Ziche, M. (1998): Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor. Lab. Invest. 78, 1109-1119.
6. Folkman, J., D'Amore, P. A. (1996): Blood vessel formation: What is its molecular basis? Cell 87, 1153 -1155.
7. Fong, G. H., Rossant, J., Gertsenstein, M., Breiman, M. L. (1995): Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70.
8. Fox, P. L., Sa, G., Dobrowolski, S. F., Stacey, D. W. (1994): The regulation of endothelial cell motility by p21 ras. Oncogene 9, 3519-3526.
9. Gotoh, Y., Nishida, E., Yamashita, T., Hoshi, M., Kawakami, M., Sakai, H. (1990): Microtubule-associated-protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells. Identity with the mitogen-activated MAP kinase of fibroblastic cells. Eur. J. Biochem. 193, 661-669.
10. Hanahan, D. (1997): Signaling vascular morphogenesis and maintenance. Science 277, 48-50.
11. Heldin, C. H. (1995): Dimerization of cell surface receptors in signal transduction. Cell 80, 213-223.
12. Hessen, C., Dowdle, E. B. (1980): Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102, 196-202.
13. Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., Shibuya, M. (1998): Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA 95, 9349-9354.
14. Joukov, V., Kaipainen, A., Jeltsch, M., Pajusola, K., Olofsson, B., Kumar, V., Eriksson, U., Alitalo, K. (1997): Vascular endothelial growth factors VEGF-B and VEGF-C. J. Cell. Physiol. 173, 211-215.
15. Joukov, V., Pajusola, J., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., Alitalo, K. (1996): A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4(VEGFR-3) and KDR(VEGFR-2) receptor tyrosine kinases. EMBOJ. 15, 290-298.
16. Kabarowski, J. H. S., Allen, P. B., Wiedemann, L. M. (1994): A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells. EMBO J. 13, 5887-5895.
17. Lewis, J. M., Baskaran, R., Taagepera, S., Schwartz, M. A., Wang, J. Y. J. (1996): Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. Proc. Natl. Acad. Sci. USA 93, 15174-15179.
18. Mandriota, S. J., Seghezzi, G., Vassalli, J.-D., Ferrara, N., Wasi, S., Mazzieri, R., Mignatti, P., Pepper, M. S. (1995): Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J. Biol. Chem. 270, 9709-9716.
19. Maru, Y., Yamaguchi, S., Shibuya, M. (1998a): Flt-1, a receptor for vascular endothelial growth factor, has transforming and morphogenic potentials. Oncogene 16, 2585-2595.
20. Maru, Y., Yamaguchi, S., Takahashi, T., Ueno, H., Shibuya, M. (1998b): Virally activated ras cooperates with integrin to induce tubulogenesis in sinusoidal endothelial cell lines. J. Cell. Physiol. 176, 223-234.
21. Maru, Y., Afar, D. E., Witte, O. N., Shibuya, M. (1996): The dimerization property of glutathione S-transferase partially reactivates Bcr-Abl lacking the oligomerization domain. J. Biol. Chem. 271, 15353-15357.
22. McWhirter, J. R., Galasso, D. L., Wang, J. Y. J. (1993): A coiled-coil oligomerization Domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol. Cell Biol. 13, 7587-7595.
23. Mintz, G. R. (1993): An irreversible serine protease inhibitor. BioPharm. 6, 34-38.
24. Montesano, R., Pepper, M. S., Mohle-Steinlein, U., Risau, W., Wagner, E. F., Orci, L. (1990): Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 62, 435-445.
25. Noda, M., Ko, M., Ogura, A., Liu, D., Amano, T., Takano, T., Ikawa, Y. (1985): Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line. Nature 318, 73-75.
26. Olofsson, B., Korpelainen, E., Pepper, M. S., Mandriota, S. J., Aase, K., Kumar, V., Gunji, Y., Jeltsch, M. M., Shibuya, M., Alitalo, K., Eriksson, U. (1998): Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc. Natl. Acad. Sci. USA 95, 11709-11714.
27. Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S., Martin, G. R. (1992): A simple quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519-528.
28. Pendergast, A. M., Quilliam, L. A., Cripe, L. D., Bassig, C. H., Dai, Z., Li, N., Batzer, A., Rabun, K. M., Der, C. J., Schlessinger, J., Gishizly, M. L. (1993): Bcr-Abl-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75, 175-185.
29. Pepper, M.S., Ferrara, N., Orci, L., Montesano, R. (1991): Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181, 902-906.
30. Puil, L., Liu, J., Gish, G., Mbamalu, G., Bowtell, D., Pelicci, P. G., Arlinghaus, R., Pawson, T. (1994): Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J. 13, 764-773.
31. Pumiglia, K. M., Decker, S. J. (1997): Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA 94, 448-452.
32. Raitano, A. B., Halpern, J. R., Hambuch, T. M., Sawyers, C. L. (1995): The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc. Natl. Acad. Sci. USA 92, 11746-11750.
33. Risau, W. (1997): Mechanisms of angiogenesis. Nature 386, 671-674.
34. Sabapathy, K. T., Pepper, M. S., Kiefer, F., Mohle-Steinelein, U., Tacchini-Cottier, F., Fetka, I., Breier, G., Risau, W., Carmeliet, P., Montesano, R., Wagner, E. F. (1997): Polyoma middle T-induced vascular tumor formation: The role of the plasminogen activator/ plasmin system. J. Cell Biol. 137, 953-963.
35. Sachs, M., Weidner, K. M., Brinkmann, V., Walther, I., Obermeier, A., Ullrich, A., Birchmeier, W. (1996): Motogenic and morphogenic activity of epithelial receptor tyrosine kinases. J. Cell Biol. 133, 1095-1107.
36. Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., Qin, Y. (1995): Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70-74.
37. Sawano, S., Takahashi, T., Yamaguchi, S., Aonuma, M., Shibuya, M. (1996): FIt-1 but not KDR/Flk-1 tyrosine Kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ. 7, 213-221.
38. γ. Biochem. Biophys. Res. Commun. 238, 487-491.
39. Schlaepfer, D. D., Jones, K. C., Hunter, T. (1998): Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: Summation of both c-src- and focal adhesion kinase-initialed tyrosine phosphorylation events. Mol. Cell. Biol. 18, 2571-2585.
40. Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S., Shibuya, M. (1995): A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10, 135-147.
41. Seghezzi, G., Patel, S., Ren, C. J., Gualandris, A., Pintucci, G., Robbins, E. S., Shapiro, R. L., Galloway, A. C., Rifkin, D. B., Mignatti, P. (1998): Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J. Cell Biol. 141, 1659-1673.
42. Senger D. R. (1996): Molecular framework for angiogenesis: A complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am. J. Pathol. 149, 1-7.
43. Senger, D. R., Claffey, K. P., Benes, J. E., Perruzzi, C. A., Sergiou, A. P., Detmar, M. (1997): Angiogenesis prompted by vascular endothelial growth factor: regulation through α1β1 and α2β1 integrins. Proc. Natl. Acad. Sci. USA 94, 13612-13617.
44. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., Schuh, A.C. (1995): Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66.
45. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., Klagsbrun, M. (1998): Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745.
46. Soldi, R., Mitola, S., Strasly, M., Defilippi, P., Tarone, G., Bussolino, F. (1999): Role of ανβ3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J. 18, 882-892.
47. Sosnowski, R. G., Feldman, S., Feramisco, J. (1993): Interference with endogenous Ras function inhibits cellular responses to wounding. J. Cell Biol. 121, 113-119.
48. γ pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene 14, 2079-2089.
49. Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, C., Gospodarowicz, D., Bohlen, P. (1992): Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187, 1579-1586.
50. Wary, K. K., Mainiero, F., Isakoff, S. J., Marcantonio, E. E., Giancotti, F. G. (1996): The adaptor protein She couples a class of integrins to the control of cell cycle progression. Cell 87, 733-743.
51. Wojnowski, L., Zimmer, A. M., Beck, T. W., Hahn, H., Bernal, R. Rapp, U. R., Zimmer. A. (1997): Endothelial apoptosis in Braf-deficient mice. Nature Genet. 16, 293-297.